Free Trial

TFF Pharmaceuticals (TFFP) SEC Filings & 10K Form

TFF Pharmaceuticals logo
$1.97
-0.53 (-21.20%)
(As of 11/1/2024 ET)

Recent TFF Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/06/2024
7:00 AM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
4:41 PM
ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:42 PM
Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:43 PM
COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:43 PM
Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:44 PM
MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:44 PM
Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:46 PM
TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:40 PM
KING THOMAS BRAXTON (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
7:32 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:29 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:03 PM
TFF Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:04 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:13 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
TFF Pharmaceuticals (Subject)
Form SC 13G
05/08/2024
3:26 PM
CARLSON CAPITAL L P (Filed by)
TFF Pharmaceuticals (Subject)
Form SC 13G/A
05/06/2024
11:15 PM
TFF Pharmaceuticals (Filer)
Form EFFECT
05/01/2024
9:54 AM
TFF Pharmaceuticals (Filer)
Form 424B4
04/29/2024
11:15 PM
TFF Pharmaceuticals (Filer)
Form EFFECT
04/29/2024
6:15 AM
TFF Pharmaceuticals (Filer)
Form S-1/A
04/29/2024
5:06 AM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:32 PM
TFF Pharmaceuticals (Filer)
Form S-1/A
04/22/2024
7:49 PM
Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:49 PM
COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:50 PM
Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:51 PM
MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:52 PM
Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:52 PM
Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:53 PM
KING THOMAS BRAXTON (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:47 PM
TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:48 PM
ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:24 PM
TFF Pharmaceuticals (Filer)
Form ARS
04/22/2024
3:24 PM
TFF Pharmaceuticals (Filer)
Form ARS
04/22/2024
3:19 PM
TFF Pharmaceuticals (Filer)
Form DEF 14A
04/22/2024
3:20 PM
TFF Pharmaceuticals (Filer)
Form DEFA14A
04/18/2024
4:20 PM
TFF Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/08/2024
5:41 AM
TFF Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2024
3:05 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM
TFF Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
7:00 AM
TFF Pharmaceuticals (Filer)
Form 424B5
02/14/2024
5:48 PM
LYTTON LAURENCE W (Filed by)
TFF Pharmaceuticals (Subject)
Form SC 13G/A
12/19/2023
5:07 AM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

12/12/2023
11:15 PM
TFF Pharmaceuticals (Filer)
Form EFFECT
12/08/2023
3:52 PM
TFF Pharmaceuticals (Filer)
Form S-3/A
12/04/2023
4:25 PM
Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2023
4:25 PM
Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2023
4:26 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
4:27 PM
Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:28 PM
Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:29 PM
ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:30 PM
MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:31 PM
Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:14 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:41 PM
TFF Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2023
3:06 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TFFP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners